(Clearwisdom.net) In Mainland China, when you type in "organ transplant" on the patent website, it will show 123 organ transplant-related patents from 1985 to April 2005. One patent in 2005, 12 patents in 2004, 22 patents in 2003, 20 patents in 2002, 11 patents in 2001, 16 patents in 2000,12 patents in 1999, 32 patents in 1998, 5 patents in 1997, 5 patents in 1996, 5 patents in 1995, 5 patents in 1994, 4 patents in 1993, and 1 patent in 1992, and 1 patent in 1985 - for a total of 123.

The number of patents by applicants from Mainland China is 62. The number of patents by applicants from Taiwan and other countries is 61.

The results from analyzing the 123 patents:

We noticed an obvious difference in quantity before and after 1999. From 1999 to 2005, there were 94 patents in seven years. (In Mainland China, it takes about one and a half years to obtain a patent. The actual numbers are way beyond what we saw listed, but let's just use this number for now.) This gives an average of 13.4 patents a year; from 1985 to 1998, there were 29 patents for those fourteen years, averaging 2 patents a year. After 1999, the average number of patents was six times higher. Even counting from 1993 to 1998, there were 27 patents, averaging 4.5 a year. The recent number is still three times higher. The number of organ transplant-related patents has risen dramatically since 1999.

From 1985 to 1998, there were 22 organ transplant-related patents applied for outside of China, while there were 7 applied for from inside China. The patents from abroad were three times the number in China. The seven patents from China were for apparatus, none for pharmacy or basic research. From 1999 to 2005, there were 39 patents applied for outside of China, while there were 55 patents applied for from China. In 1999, there were 10 patents from outside China and only 2 patents from China. In 2003, there were 16 patents from China compared to only 6 patents from abroad, almost 3 times the number from abroad. In 2004, there were 12 patents from China, none from outside China. During this period, there were a large number of patents applied for in pharmacy, research and practical clinical usage. The organ transplant field in Mainland China has been developing rapidly.

Before 1999, there were only two colleges that together obtained two research patents. One was from Xian Medical College in 1998 and the other was from the Chinese Medicine Research College in 1993. From 2002 to 2004, a three-year period, there were nine colleges that applied for 13 patents, and they were all top rated colleges. Sichuan University applied for one in 2003, two in 2004. Baoding Hebei University Pharmacy College in Hebei Province applied for one in 2004. Beijing University applied for one in 2003 and 2004. Nanjing University applied for one in 2004. Xian Jiaotong University applied for one in 2004. Chinese Pharmacy College applied for one in 2004. Zhejiang University applied for one in 2002 and 2003. Qinghua University applied for one in 2002. Fudan University applied for one in 2002. From the dates of patent applications and the fact that such applications would take 2-3 years to complete, it can be deduced that these universities received the research projects at around the same time, that is, around 1999.

Inferences from this analysis:

1. Because the CCP imported large amounts of organ transplant-related medicine and technology before 1999, it caused an increase in related patents abroad.
   
2. After 1999, the CCP made it a national policy to request that top colleges be involved in organ transplant-related basic theory, pharmacy and clinical product research. The development of this area was very fast because it was guaranteed that a large amount of clinical supplies would be provided.

From our analysis, we discovered pharmacy companies abroad had applied for patents in Mainland China many times. This means that there was a market there for them to sell the medicine and related apparatus. If we could clarify the truth to these companies, we might be able to cut the supply of organ transplant-related medicine and apparatus, and be able to save many Dafa practitioners' lives. If those personnel related to this work can help to investigate, the truth will be revealed and expose the evil. It is a bit complicated since some big companies might not cooperate out of concerns for their profit, so we need to deal with different situations differently in this unusual time:

(A) Strive to have companies temporarily hold off from selling organ transplant-related medicine and apparatus.

(B) Strive to get approval from the Pharmacy Association and FDA to put a limit to some big companies' business-only oriented behavior.

(C) Strive to get agreements from big companies to hold off from selling until after the investigation.

(D) Strive to get the companies to request a list of names of organ recipients and medicine given according to those people (may need to cooperate with the Investigation Committee).

(E) The bottom line is to ask the big companies to hold off selling before July (the Mainland organ transplant-related law takes effect in July)

The original content of the patents may be obtained with the help of the patent service companies. It is better to download the entire article, as it may be used as evidence in the future.